Search PubMed⌕ Search

Biomedical subjects

M Visser

Publications and source records attributed to M Visser.

At least 109 records · Page 6Linked to original sources
PubMed1995

Validation of dietary history method in a group of elderly women using measurements of total energy expenditure.

The objective of the present study was to validate energy intake data, obtained by dietary history, in twelve elderly women aged 69-82 years. Energy and protein intakes were obtained using the dietary history method with a reference period of 30 d. Reported energy intake was compared with total energy expenditure (TEE) measured on two consecutive days in a respiration chamber. Reported protein intake was compared with mean N excretion from four 24 h urine collections. Mean reported energy intake was 7.2 (SD 1.5) MJ/d which was lower than TEE (P = 0.059). Reported protein intake was 64 (SD 13) g/d and lower than estimated protein intake (P = 0.053). The percentage underestimation was not related to body weight or percentage body fat. Subjects with a relatively high TEE or a relatively high estimated protein intake underestimated their energy intake to a greater extent. The discrepancy between reported energy intake and TEE was positively associated with the discrepancy between reported and estimated protein intakes. The results of this present study show an underestimation of energy intake of about 12% when using the dietary history method. Physical activity diaries completed in the chamber and during 4 d at home, as well as pedometer counts, indicated a higher level of physical activity in the free-living situation compared with the chamber situation. This suggests that the actual underestimation of energy intake may be even higher in this group of elderly women. These results have implications for the use of the dietary history method in, for example, epidemiological studies carried out in elderly subjects.

Aged↗
PubMed1994

No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity.

In this paper we investigated the effect of fluoxetine (60 mg/d) on serum lipids, glucose and insulin concentrations and blood pressure by means of a randomized, double-blind placebo controlled trial. Thirty-eight overweight (BMI: 26-30 kg/m2), nondiabetic, nonhypertensive men with an abdominal fat distribution (waist/hip ratio: > 0.97) received dietary advice and placebo or fluoxetine for 12 weeks. The changes in serum parameters and blood pressure in the fluoxetine treated group were not different from the placebo treated group, despite a significantly larger weight loss in the fluoxetine group. In both groups serum total-cholesterol concentrations, serum LDL-cholesterol concentrations and the HDL/LDL ratio were significantly improved after treatment. Reductions in fasting glucose concentration and systolic blood pressure were only significant in the placebo group. A reduction of serum triglycerides and an increase of HDL-cholesterol were found in the fluoxetine treated group. In the total study population the changes in serum lipids seemed to be more strongly related to the change in total body fat or subcutaneous abdominal fat (assessed by MRI) compared to the change in visceral fat. The improvement of most of the serum lipids was related to the change in total body fat independent of the mechanism for attaining this fat loss. Our results indicate that fluoxetine treatment has no specific effect beyond that expected for weight loss on serum lipid, glucose and insulin concentrations, and blood pressure in overweight men.

Abdominal Fat↗
PubMed1994

Prediction equations for the estimation of body composition in the elderly using anthropometric data.

To study the relationship between health and nutritional status in elderly populations, information about body composition is essential. To collect this information in large epidemiological studies, practical methods based on anthropometric data must be available. In the present study the relationship between body composition, determined by densitometry, and anthropometric data in 204 elderly men and women, aged 60-87 years, was analysed. Existing prediction equations described in the literature, and mainly based on young and middle-aged subjects, generally underestimated percentage body fat in the elderly study population. Therefore, new prediction equations were developed, based on sex and the sum of two (biceps and triceps) or four (biceps, triceps, suprailiaca and subscapula) skinfolds or the body mass index (BMI). Addition of age or body circumferences to the models did not improve the prediction of body density. Internal cross validation and external validation revealed that the formulas are valid for the estimation of body density in elderly subjects. The standard errors of estimate of the three models, expressed as percentage body fat, were 5.6, 5.4 and 4.8% respectively.

Aged↗
PubMed1994

Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis.

The effect on the oropharyngeal and intestinal microflora and the efficacy and tolerance of loracarbef (200 mg b.i.d. for 7 days) versus amoxicillin (500 mg t.i.d. for 7 days) were compared in 80 patients with bronchitis. The oropharyngeal samples of 18% of patients in the amoxicillin group and 5% of patients in the loracarbef group revealed a new Gram-negative species around days 8-10. The presence of other aerobic bacteria than found at baseline in the faeces occurred in 38% of patients treated with amoxicillin compared with 31% in the loracarbef group on days 8-10. After treatment, no loracarbef- or amoxicillin-resistant aerobic Gram-negative bacteria were found in faecal samples in the loracarbef group, while amoxicillin- or loracarbef-resistant (E. coli) strains appeared in 35% of patients receiving amoxicillin (p < 0.001). Treatment success occurred by days 8-10 in all 40 patients receiving loracarbef, compared with 90% in the amoxicillin group, on days 21-28, in 93% and 90% respectively. The results of this study indicate that the use of loracarbef leads to minor changes in the normal oropharyngeal and intestinal microflora compared with amoxicillin, while almost no resistant Gram-negative bacteria emerge after treatment with loracarbef.

Acute Disease↗
PubMed1993

Efficacy of abamectin against ectoparasites of cattle.

Four trials, using 48 European breed cattle, were conducted to evaluate the efficacy of abamectin against the louse species Linognathus vituli, Haematopinus eurysternus and Damalinia bovis and against the mange mites Sarcoptes scabiei var bovis and Psoroptes ovis. Animals were allocated by restricted randomisation based on parasite counts to treatment with abamectin at a dose of 200 micrograms/kg given subcutaneously or to an untreated control group. Ectoparasites were counted before treatment and at weekly intervals thereafter for eight weeks. L. vituli, H eurysternus and S scabiei var bovis were eliminated (P < 0.05) by day 7 after abamectin treatment. An efficacy of more than 99 per cent was recorded against P ovis mange mites. The biting louse D bovis was not controlled. Abamectin treatment increased the weight gain of cattle infested with ectoparasites.

Animals↗
PubMed1993

Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry.

The aim of the present study was to investigate the usefulness of abdominal diameters to indicate visceral fat, their relationship with serum lipids and their capability of detecting changes in visceral fat. Before and after weight loss, visceral and subcutaneous fat, and the sagittal and transverse diameters were assessed by magnetic resonance imaging (MRI) in forty-seven obese men and forty-seven premenopausal obese women with an initial body mass index of 31.0 (SD 2.4) kg/m2. In a subsample (n 21), diameters, were also measured by anthropometry in the standing and supine positions. They were strongly correlated with the diameters derived from the MRI scans. Serum levels of total and HDL-cholesterol and triacylglycerol were measured before weight loss. In women the sagittal diameter correlated less strongly with visceral fat than anthropometrically-assessed waist circumference and waist:hip ratio (WHR). In men these associations were comparable. Changes in visceral fat with weight loss were more strongly correlated with changes in the sagittal diameter and sagittal:transverse diameter ratio (STR) than with changes in waist circumference or WHR in men. In women, changes in the anthropometric variables and the separate diameters (except STR) were not associated with visceral fat loss. In men, but not in women, both the sagittal diameter and the visceral fat area were related to serum lipids. It is concluded that the sagittal diameter and STR may have advantages over waist circumference and WHR in men, particularly in assessing changes in visceral fat, but this could not be demonstrated in women. The ability to predict visceral fat from circumferences and diameters or their ratios is, however, limited in obese men and women.

Abdomen↗
PubMed1993

The effect of fluoxetine on body weight, body composition and visceral fat accumulation.

In this study the effect of fluoxetine versus placebo treatment on body weight, body composition and abdominal fat areas, assessed from three magnetic resonance imaging scans at umbilicus level, was investigated. Thirty-eight abdominal overweight men aged 41 +/- 7 years (mean +/- s.d.), BMI 27.9 +/- 1.2 kg/m2 and WHR 0.97 +/- 0.03 were given dietary advice and a placebo (n = 20) or fluoxetine treatment (n = 18, 60 mg/day) for 12 weeks after a placebo run-in of two weeks. Measurements were carried out during run-in and at week 12 of treatment. The treatment groups did not differ at the start of the study. After treatment, weight loss (on average) was observed in both groups: -2.4 +/- 0.6 kg and -5.9 +/- 0.7 kg for the placebo and fluoxetine groups, respectively. Weight loss was significantly larger in the fluoxetine group (P = 0.0004). The reduction of fat mass tended to be larger (P = 0.08), and the reduction of fat-free mass was considerably larger in the fluoxetine group (P = 0.0005). Absolute (and proportional) changes in visceral and subcutaneous fat areas (cm2) were +2 +/- 26 (+1%) and -9 +/- 26 (-4%) in the placebo group, and -9 +/- 30 (-3%) and -30 +/- 27 (-13%) in the fluoxetine group. In both groups the proportional change in subcutaneous fat area was larger than the change in visceral fat (P < 0.02). Only in the fluoxetine group was the decrease in subcutaneous fat area significant, and larger compared to the placebo group (P = 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

Abdomen↗
PubMed1992

[Veterinary dentistry (5). Instruments for extractions in pets].

The increasing dental care of companion animals requires good instruments. The instruments needed to perform extractions well are described in this article. Research into the use of the most appropriate (used in humans) instruments has led to the establishment of a set of instruments for use for simple and complicated extractions in dogs and cats.

Animals↗
PubMed1992

Herpes virus infection of endothelium: new insights into atherosclerosis.

Several pieces of evidence suggest that vascular endothelium may be a site of latent herpetic viral infection, and that activation of such infection might cause or aggravate atherosclerosis. The present studies which utilized HSV-1 infection of cultured endothelial monolayers, provide insights into two phenomena seemingly relevant in considerations of atherosclerosis. Thus, mechanisms are reported by which infected endothelium may be damaged by marginated inflammatory cells, and be transformed from an anticoagulant to a procoagulant tissue. First, granulocytes are attracted to, and avidly bind, endothelium infected for very brief periods. This interaction is associated with denudation of intact cells as well as actual cytolysis through release of PMN proteases and toxic oxygen species. Second, several potentially additive abnormalities of HSV-infected endothelium would seem to foster coagulation. These include: a) its loss of surface heparans and thrombomodulin; b) its inability to synthesize prostacyclin with associated incapacity to deter platelet adhesion; c) its disordered membrane lipid conformation which is likely associated with excessive surface thrombin generation; and d) its unique ability to generate and release tissue factor. We speculate that mechanical abrasion may reactivate latent herpes (HSV or CMV) infection in endothelial cells particularly those exposed to high shear forces--for instance, at vessel bifurcations. This may underlie the endothelial damage, clotting and atheroma formation commonly found at these sites.

Animals↗
PubMed1991

Quantum wormholes.

Explore the source record for details and available documents.

Journal Article↗
PubMed1991

Amoxicillin-clavulanate prophylaxis against wound infections after clean-contaminated surgery. A controlled, randomized, prospective study.

In a single-blind, prospective randomized and controlled trial, amoxicillin-clavulanate was compared with gentamicin plus clindamycin as perioperative prophylaxis for 24 hours in clean-contaminated abdominal surgery. Proven infections of the abdominal incision occurred in one of 59 evaluable patients given amoxicillin-clavulanate and one of 43 with gentamicin/clindamycin. In the latter group there was also one incisional perineal wound infection. At follow-up enquiry by telephone around postoperative day 30, four patients in the amoxicillin-clavulanate group reported minor wound discharge for which they had not sought medical attention. Intraperitoneal infection occurred in one patient of that group, and in three of the gentamicin/clindamycin group. Both regimens thus were effective and safe as prophylaxis in clean-contaminated abdominal surgery.

Adult↗